These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 3401633)

  • 1. Effect of a Paf antagonist, WEB 2086, on airway microvascular leakage in the guinea-pig and platelet aggregation in man.
    Evans TW; Dent G; Rogers DF; Aursudkij B; Chung KF; Barnes PJ
    Br J Pharmacol; 1988 May; 94(1):164-8. PubMed ID: 3401633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor.
    Casals-Stenzel J; Muacevic G; Weber KH
    J Pharmacol Exp Ther; 1987 Jun; 241(3):974-81. PubMed ID: 3598913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Y-24180, a platelet-activating factor-receptor antagonist, on the antigen-induced airway microvascular leakage in guinea pigs.
    Iwahisa Y; Yamaguchi S; Kagoshima M; Terasawa M
    Jpn J Pharmacol; 1996 Nov; 72(3):209-15. PubMed ID: 8957681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
    Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH
    J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of inhaled lyso-platelet-activating factor on airway microvascular leakage in the guinea pig.
    Sakamoto T; Elwood W; Barnes PJ; Chung KF
    J Appl Physiol (1985); 1993 Mar; 74(3):1117-22. PubMed ID: 8482649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of the selective PAF antagonist CIS-19 on PAF- and antigen-induced bronchoconstriction, microvascular leakage and bronchial hyperreactivity in guinea-pigs.
    Lin CH; Ko FN; Ishii H; Ishikawa T; Chen IS; Teng CM; Kuo HP
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb; 355(2):210-6. PubMed ID: 9050014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative assessment of increased airway microvascular permeability to 125I-labelled plasma fibrinogen induced by platelet activating factor and bradykinin.
    Pedersen KE; Rigby PJ; Goldie RG
    Br J Pharmacol; 1991 Sep; 104(1):128-32. PubMed ID: 1664758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-activating factor mediates the ozone-induced increase in airway microvascular leakage in guinea pigs.
    Kaneko T; Ikeda H; Fu L; Nishiyama H; Okubo T
    Eur J Pharmacol; 1995 Mar; 292(3-4):251-5. PubMed ID: 7796863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of a potent platelet-activating factor antagonist: Ro 24-4736.
    Crowley HJ; Yaremko B; Selig WM; Janero DR; Burghardt C; Welton AF; O'Donnell M
    J Pharmacol Exp Ther; 1991 Oct; 259(1):78-85. PubMed ID: 1656030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of PAF-induced histamine secretion and bronchoconstriction by WEB 2086.
    Chand N; Pillar J; Nolan K; Diamantis W; Sofia RD
    Res Commun Chem Pathol Pharmacol; 1990 Jan; 67(1):155-8. PubMed ID: 1691522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interference by the novel PAF-acether antagonist WEB 2086 with the bronchopulmonary responses to PAF-acether and to active and passive anaphylactic shock in guinea-pigs.
    Pretolani M; Lefort J; Malanchère E; Vargaftig BB
    Eur J Pharmacol; 1987 Aug; 140(3):311-21. PubMed ID: 3653247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of the Paf antagonist WEB 2086 and its hetrazepine analogues with human platelets and endothelial cells.
    Korth R; Hirafuji M; Keraly CL; Delautier D; Bidault J; Benveniste J
    Br J Pharmacol; 1989 Oct; 98(2):653-61. PubMed ID: 2555017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of WEB 2086, an antagonist to the receptor for platelet-activating factor (PAF), on PAF-induced responses in the horse.
    Foster AP; Lees P; Andrews MJ; Cunningham FM
    Equine Vet J; 1992 May; 24(3):203-7. PubMed ID: 1318830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-activating factor (PAF) receptor antagonists inhibit arachidonic acid induced platelet aggregation in rabbit whole blood.
    Ammit AJ; O'Neill C
    Lipids; 1991 Dec; 26(12):1189-92. PubMed ID: 1668116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist.
    Tsunoda H; Sakuma Y; Harada K; Muramoto K; Katayama S; Horie T; Shimomura N; Clark R; Miyazawa S; Okano K
    Arzneimittelforschung; 1990 Nov; 40(11):1201-5. PubMed ID: 2085331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological actions of Y-24180, a new specific antagonist of platelet activating factor (PAF): II. Interactions with PAF and benzodiazepine receptors.
    Takehara S; Mikashima H; Muramoto Y; Terasawa M; Setoguchi M; Tahara T
    Prostaglandins; 1990 Dec; 40(6):571-83. PubMed ID: 1965554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonist.
    Herbert JM; Bernat A; Valette G; Gigo V; Lale A; LaPlace MC; Lespy L; Savi P; Maffrand JP; Le Fur G
    J Pharmacol Exp Ther; 1991 Oct; 259(1):44-51. PubMed ID: 1656029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited interference of specific Paf antagonists with hyper-responsiveness to Paf itself of lungs from actively sensitized guinea-pigs.
    Pretolani M; Lefort J; Vargaftig BB
    Br J Pharmacol; 1989 Jun; 97(2):433-42. PubMed ID: 2474345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the actions of platelet activating factor (PAF) antagonists WEB 2170 and WEB 2086 in the horse.
    Foster AP; Cunningham FM; Andrews MJ; Lees P
    J Vet Pharmacol Ther; 1993 Dec; 16(4):477-87. PubMed ID: 8126765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of airway narrowing caused by inhaled platelet-activating factor. Role of airway microvascular leakage.
    Tokuyama K; Lötvall JO; Barnes PJ; Chung KF
    Am Rev Respir Dis; 1991 Jun; 143(6):1345-9. PubMed ID: 2048823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.